LOGIN  |  REGISTER

List of Health Technology Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 79.36
0.08 0.10
1.04M
456.87M
US$ 36.260B
US$ 217.62
-7.27 -3.23
836,281
162.35M
US$ 35.330B
US$ 96.99
1.90 2.00
201,663
86.66M
US$ 8.410B
US$ 59.20
1.02 1.75
808,730
128.14M
US$ 7.590B
US$ 38.12
1.19 3.22
490,159
172.09M
US$ 6.560B
US$ 14.31
0.00 0.00
0
422.39M
US$ 6.040B
US$ 19.90
-0.01 -0.05
169,992
120.00M
US$ 2.390B
US$ 22.03
0.65 3.04
383,715
96.11M
US$ 2.120B
US$ 76.00
-0.40 -0.52
139,148
27.47M
US$ 2.090B
US$ 43.20
-1.30 -2.92
234,456
46.32M
US$ 2.000B
US$ 10.70
-0.04 -0.37
205,938
160.99M
US$ 1.720B
US$ 9.21
0.09 0.99
1.48M
172.17M
US$ 1.590B
US$ 14.70
-0.03 -0.20
752,753
107.00M
US$ 1.570B
US$ 25.19
-0.19 -0.75
68,797
58.12M
US$ 1.460B
US$ 11.27
-0.05 -0.44
440,357
115.03M
US$ 1.300B
US$ 19.73
-0.03 -0.15
211,454
63.69M
US$ 1.260B
US$ 14.53
0.04 0.28
356,788
85.15M
US$ 1.240B
US$ 9.35
2.54 37.30
1,000
107.64M
US$ 1.010B
US$ 31.62
0.19 0.60
36,335
30.41M
US$ 961.560M
C$ 11.18
0.18 1.64
107,979
52.48M
C$ 586.730M
US$ 28.35
0.02 0.07
62,181
20.07M
US$ 568.980M
US$ 1.43
0.00 0.00
0
371.88M
US$ 531.790M
US$ 4.13
-0.03 -0.72
92,814
115.52M
US$ 477.100M
US$ 4.50
-0.02 -0.44
505,776
104.27M
US$ 469.220M
US$ 6.60
-0.34 -4.90
182,664
60.85M
US$ 401.610M
C$ 2.07
-0.03 -1.43
174,488
165.88M
C$ 343.370M
US$ 15.96
0.28 1.79
39,389
20.27M
US$ 323.510M
US$ 19.02
0.36 1.93
16,947
14.93M
US$ 283.970M
US$ 3.44
-0.01 -0.32
231,967
80.54M
US$ 276.980M
US$ 3.16
-0.15 -4.53
18,151
66.44M
US$ 209.950M
US$ 11.20
4.92 78.34
1.71M
16.17M
US$ 181.100M
US$ 4.06
-0.05 -1.22
59,623
37.15M
US$ 150.830M
US$ 1.90
0.15 8.57
169,911
73.84M
US$ 140.300M
US$ 2.35
0.00 0.00
0
49.43M
US$ 116.160M
US$ 7.72
0.28 3.76
13,266
13.67M
US$ 105.530M
US$ 4.94
0.11 2.28
204,583
18.42M
US$ 90.990M
C$ 1.02
-0.16 -13.56
66,381
74.08M
C$ 75.560M
US$ 0.78
0.01 1.31
28,853
86.02M
US$ 67.100M
US$ 3.95
0.25 6.76
91,523
16.26M
US$ 64.230M
US$ 2.05
0.01 0.49
43,001
31.02M
US$ 63.590M
US$ 3.01
-0.10 -3.06
816
16.39M
US$ 49.250M
US$ 1.86
0.18 10.39
284,926
26.35M
US$ 49.010M
US$ 1.61
-0.24 -12.97
14,755
24.67M
US$ 39.720M
US$ 1.31
-0.07 -5.07
73,096
27.99M
US$ 36.670M
US$ 0.43
0.00 0.00
0
78.73M
US$ 34.010M
C$ 0.35
-0.05 -12.50
11,000
59.14M
C$ 20.700M
US$ 2.14
0.03 1.42
67,945
8.71M
US$ 18.640M
US$ 0.21
0.00 0.00
0
82.96M
US$ 17.180M
US$ 3.31
0.04 1.22
9,148
4.27M
US$ 14.130M
C$ 0.13
0.00 0.00
0
93.47M
C$ 11.680M
C$ 0.06
0.00 0.00
0
133.13M
C$ 7.990M
US$ 1.51
0.08 5.59
29,670
4.22M
US$ 6.370M
US$ 2.44
-0.04 -1.57
31,282
2.49M
US$ 6.080M
US$ 0.26
-0.01 -4.07
418,108
22.41M
US$ 5.800M
US$ 0.74
-0.04 -4.85
16,838
5.67M
US$ 4.200M
US$ 1.58
-0.05 -3.07
17,942
1.86M
US$ 2.940M
US$ 0.54
0.00 0.00
0
3.81M
US$ 2.040M
C$ 0.90
0.00 0.00
0
1.55M
C$ 1.400M
US$ 0.13
0.0014 1.11
347,079
10.44M
US$ 1.340M
C$ 0.15
0.00 0.00
3,133
6.40M
C$ 928K
C$ 0.01
0.00 0.00
0
89.59M
C$ 896K
C$ 0.005
0.00 0.00
0
173.26M
C$ 866K
C$ 0.02
0.00 0.00
0
47.62M
C$ 714K
US$ 0.008
0.00 0.00
0
37.67M
US$ 301K
US$ 67.48
0.00 0.00
983,791
-
US$ -

Latest Health Technology Stock News


MultiPlan Announces Comprehensive Refinancing

Maturities extended for entire debt capital structure, with earliest funded maturity in 2030 and remainder in 2031 Refinancing enables continued investment in the business to support Vision 2030 transformation plan Broad based support from investors with participation from certain ad hoc groups of noteholders and lenders through a Transaction Support Agreement collectively representing nearly 78% of the Company’s existing funded debt NEW YORK / Dec 24, 2024 / Business... Read more


OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

WALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that William J. Febbo, Chief Executive Officer (CEO) and Board Member, will be departing the Company, effective as of December 31, 2024, to pursue other opportunities. Mr. Febbo will provide the Company with... Read more


Mangoceuticals Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced the acquisition of patent number WO 2023/086647 PCT/US2022/049857, for mushroom-derived compositions and methods of treatment. This new addition to MangoRx’s intellectual property portfolio highlights the Company’s... Read more


Streamline Health Solutions Expands Presence In Texas with 400-Bed Health System for RevID

ATLANTA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID with a 400-bed, Oracle Health-EHR based health system with facilities in Western Texas. The deal was closed in partnership with Oracle Health. Streamline Health is leading an industry movement to improve hospital financial... Read more


Amwell CFO Mark Hirschhorn Expands Leadership Role

BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, has announced Chief Financial Officer (CFO) Mark Hirschhorn will take on an expanded role as chief operating officer, effective Jan. 1, 2025. Hirschhorn will now oversee the company's operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO. This move reflects Amwell’s commitment to scale its innovative... Read more


VitalHub Announces $30 Million Bought Deal Public Offering

TORONTO, Dec. 17, 2024 /CNW/ - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased to announce that it has entered into an agreement with Cormark Securities Inc. acting as lead underwriter, on behalf of a syndicate of underwriters (collectively, the "Underwriters") pursuant to which the Underwriters have agreed to purchase 2,752,300 Common Shares (the "Common Shares") from the treasury of the Company, at a price of $10.90 per Common Share... Read more


EUDA Health and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

Preliminary Discussions Underway to Establish a Joint Venture SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. Ltd. (“Guangdong Cell Biotech”), a prominent player in stem... Read more


GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

STAMFORD, Conn. / Dec 16, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference from January 12-16 in San Francisco, CA. Management will participate in a presentation on Wednesday, January 15, 2025, at 4:30 p.m. PT. Live and archived webcasts will be available on the “Events” section of the GeneDx... Read more


Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics

NEWTOWN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced a partnership with Databricks, the data and AI company, to deliver access to its Chartis™ product, which maps physician and organization affiliations, through Databricks Marketplace. This collaboration will empower healthcare organizations... Read more


HEALWELL AI to Acquire Orion Health, Creating a Global Market Leader in Healthcare Data Interoperability & Artificial Intelligence, and Launches $50 Million Bought Deal Financing

HEALWELL AI has entered into an agreement to acquire 100% of the shares of Auckland, New Zealand based Orion Health Holdings Limited (“Orion Health”), a subscription license and services revenue business serving marquee public sector clients globally with data interoperability and healthcare navigation products and services. The two organisations are perfectly aligned on a combined mission to revolutionize healthcare through AI and data-driven innovation positioning... Read more


GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

Wendy Barnes, Current CEO of RxBenefits, Brings Extensive Healthcare Management Experience to the Company SANTA MONICA, Calif. / Dec 16, 2024 / Business Wire / GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President and Chief Executive Officer, effective January 1, 2025. Wendy brings more than 30 years of leadership experience across the pharmacy and medical benefit... Read more


Streamline Health Solutions Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline

Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023 Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectation Company accelerated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the first half of fiscal 2025 ATLANTA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“St... Read more


Kovo+ Announces Life Offering

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2024) - Kovo+ Holdings Inc. (formerly Kovo HealthTech Corporation) (TSXV: KOVO) ("Kovo" or the "Company") is pleased to announce a best efforts private placement (the "Offering") consisting of a minimum of 20,000,000 and a maximum of 28,000,000 common shares (the "Offered Shares") of the Company at a price of $0.05 per Offered Shares for gross proceeds of a minimum of $1,000,000 and maximum of $1,400,000. Kovo... Read more


Netramark Strengthens Financial Position With $1,161,000 Raised From Warrant And Stock Option Exercise

TORONTO, Dec. 12, 2024 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the pharmaceutical industry, is pleased to announce that it has received aggregate proceeds of $1,161,000 from the exercise of 2,244,606 common share purchase warrants (the "Warrants") and 410,000 stock options (the "Stock Options") of the Company,... Read more


SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

NASHUA, N.H., Dec. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that four novel AI-driven breast cancer research abstracts have been accepted for presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS), taking place from December 10-13, 2024. These clinical abstracts highlight the latest research in breast health AI, focusing... Read more


Kovo+ Announces Management Appointments and Strategic Restructuring

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Kovo+ Holdings Inc. (TSXV: KOVO) (formerly Kovo HealthTech Corporation) ("Kovo" or the "Company") is pleased to announce the following organizational changes: Mr. Justin Anderson, formerly the Chief Restructuring Officer of the Company, has been appointed Chief Executive Officer. Mr. Brenner Adams, formerly the Interim Chief Executive Officer of the Company, has been appointed to the newly created... Read more


Phreesia Announces Third Quarter Fiscal 2025 Results

ALL-REMOTE COMPANY/WILMINGTON, Del. / Dec 09, 2024 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in.” Please... Read more


HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results

Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24. Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24. Net income per diluted share of $0.06, compared to $0.17 in Q3 FY24, with non-GAAP net income per diluted share of $0.78, compared to $0.60 in Q3... Read more


Omnicell Announces OmniSphere

Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New and Enhanced Outcomes-Centric Innovation at ASHP Midyear 2024 FORT WORTH, Texas / Dec 09, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere,... Read more


NetraMark Signs A Pilot Collaboration Agreement With A Top 5 Pharmaceutical Company

TORONTO, Dec. 9, 2024 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the pharmaceutical industry, is proud to announce that it has entered into a pilot collaboration agreement with a Top 5 pharmaceutical company. The pilot is seeking to unlock novel insights and hypotheses regarding patient populations to facilitate... Read more


Veeva Systems Announces Fiscal 2025 Third Quarter Results

Total Revenues of $699.2M, up 13% Year Over Year Subscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the board," said CEO Peter Gassner.... Read more


GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide

More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare is at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit clinicians and patients with the latest technologies and solutions. CHICAGO / Dec 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep... Read more


GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

STAMFORD, Conn. / Dec 05, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines (Nasdaq: PRAX) and Stoke Therapeutics (Nasdaq: STOK) as the founding partners to its Patient Access Program for pediatric epilepsy, which provides access to whole exome sequencing. Currently, access to a definitive genetic diagnosis in pediatric epilepsy remains limited,... Read more


GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

Determined to reach net zero emissions by 2050, GE HealthCare’s portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to drive advancements in patient care CHICAGO / Dec 04, 2024 / Business Wire / As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions with increased focus on sus... Read more


GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction

CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data CHICAGO / Dec 03, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam computed tomography (CBCT) images... Read more


HEALWELL AI Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots

HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and machine learning technology. AutoScribe's speech... Read more


Premier Appoints David Zito as President, Performance Services

CHARLOTTE, N.C. / Dec 03, 2024 / Business Wire / Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has named David (Dave) Zito as President, Performance Services, effective December 6, 2024. Zito will oversee Premier’s Performance Services segment, including the continued development and growth of the company’s enterprise-wide, AI-enabled technology businesses and Premier’s consulting practice. He will... Read more


Certara Showcases 2024 Research Wins With Over 100 Papers Published

RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100 publications secured in 2024 as well as the 12 Certara scientists included on the 2024 Stanford/Elsevier list, which highlights the top 2% of the most cited scientists across the globe. Stanford/Elsevier's Top 2% Scientist Ranking Now in its 7th iteration, the Stanford/Elsevier's... Read more


OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products. "We are thrilled to join forces with Bayer's AI Innovation... Read more


GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Acquisition positions NMP to become partner of choice for global innovators looking to bring novel radiopharmaceuticals to Japan and other Asian m... Read more


GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI

New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL accelerates workflow while improving diagnostic confidence and patient comfort. CHICAGO / Dec 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging portfolio, designed to accelerate MRI scans... Read more


GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024

Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product introductions reflect GE HealthCare’s increased R&D investment since 2022 CHICAGO / Dec 01, 2024 / Business Wire / At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more... Read more


Mobile-health Network Solutions to Present at Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference on December 3-4, 2024

SINGAPORE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced that its Co-founders and Co-CEOs, Dr. Rachel Teoh, and Dr. Siaw Tung Yeng, will present at NobleCon20 - Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL. on Wednesday,... Read more


Newtopia Reports Third Quarter 2024 Financial Results

We are well-positioned to grow via key market opportunities at the forefront of global healthcare, including the incoming U.S. administration's aim to "Make America Healthy Again" by tackling chronic disease. Commercial and Community Care-Delivery: Continued expansion with market-leading employer, provider and payvider innovation partners Growth of GLP-1s: Engagement expertise provides unique ability to facilitate sustainable health outcomes and demonstrable ROI... Read more


iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

NASHUA, N.H., Nov. 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking breast health AI technologies at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, December 1-5. Key highlights include the recent FDA-cleared ProFound Detection Version 4, clinical research presentations, and a new partnership... Read more


GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care

Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care CHICAGO / Nov 26, 2024 / Business Wire / Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America’s 2024 Annual Meeting, this innovation provides... Read more


GE HealthCare management to present at upcoming investor conferences

CHICAGO / Nov 25, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Nasdaq Investor Conference in London, England - December 10, 2024 at 11:00 am GMT / 5:00 am CT / 6:00 am ET 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA - January 14, 2025 at 4:15 pm CT / 5:15 pm ET Webcasts of these events can be accessed at the GE HealthCare website:... Read more


Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution

PURCHASE, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced today the launch of new AI-enabled capabilities to enhance its Virtual Sitter solution to improve patient safety, address workforce challenges, and enhance care delivery for hospitals and health systems. Every year, nearly 1 million hospitalized patients experience falls, with more than 30% resulting in lasting injuries. According to the CDC, falls... Read more


Veeva Systems Announces AI in Vault CRM

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE, Nov. 24, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will have immediate value by boosting field... Read more


Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

FORT WORTH, Texas / Nov 22, 2024 / Business Wire / Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 2:00 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell Since 1992, Omnicell has been committed... Read more


GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-CBCT offering. OEC Open interface expanded with additional third-party option to streamline data interface during bronchoscopy procedures. CHICAGO / Nov 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio to help... Read more


GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

Company updates medium-term framework with progress toward financial goals; increases quarterly cash dividend by approximately 17% CHICAGO / Nov 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance. The event will feature presentations from GE HealthCare President and... Read more


SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the Association for Molecular Pathology (AMP) Annual Meeting. This innovative solution provides organizations worldwide with the opportunity... Read more


Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

NEW YORK / Nov 20, 2024 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. The live presentation will take place on Wednesday, December 4, 2024 at 8:30 a.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger... Read more


Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare

SALT LAKE CITY, Nov. 20, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity threats through third parties. On... Read more


VitalHub announces SHREWD implementation with Winnipeg Regional Health Authority

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has successfully completed an implementation of its regional patient flow and whole-system visibility platform, SHREWD, to support improved patient flow and safer, more effective care coordination. SHREWD is a real-time operational management platform which supports – and gathers data from – hospitals, long-term care... Read more


Veeva Systems Announces AI in Vault CRM

CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM MADRID and PLEASANTON, Calif., Nov. 20, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will have... Read more


SCWorx Announces Completion of Equity Financing with Institutional Investors

New York, NY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp (the “Company”), on November 19th, 2024 completed an equity financing with institutional investors (the “Institutional Investors” or “Investors”). In connection with the funding, the Company sold an aggregate of 232,558 shares of common stock and warrants to purchase the same number of shares of common stock, for aggregate gross proceeds of $200,000. The Company will be registering for resale the shares... Read more


So-Young Reports Unaudited Third Quarter 2024 Financial Results

BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenues were RMB371.8 million (US$53.0 million[1]), compared with RMB385.3... Read more


GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

New Biopharma Solution Aims to Accelerate the Delivery of Precision Medicine to More Patients STAMFORD, Conn. / Nov 19, 2024 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced GeneDx Discover, a first-of-its-kind data visualization tool, which provides biopharmaceutical companies access to deidentified and aggregated genetic data - powered by GeneDx’s robust database - to improve all stages... Read more

COPYRIGHT ©2023 HEALTH STOCKS HUB